Spyre Therapeutics, Inc. · NASDAQ:SYRE
Rtw Investments, LP reported a 6.20% stake in Spyre Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Rtw Investments, LP reported a 6.20% stake in Spyre Therapeutics, Inc., 3,621,996 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 6.20%
- Shares
- 3,621,996
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RTW Investments, LP | 6.20% | 3,621,996 |
| Roderick Wong, M.D. | 6.20% | 3,621,996 |
Source
Related
- Spyre Therapeutics, Inc.
- Rtw Investments, LP
- Spyre Therapeutics, Inc. shareholders
- Schedule 13G/A · Rtw Investments, LP · Aug 14, 2026
- Schedule 13D/A · Harwin Peter Evan · Oct 9, 2026
- Form 4 · Burrows Scott L · Oct 2, 2026
- Form 4 · King-Jones Heidy · Oct 2, 2026
- Form 4 · Turtle Cameron · Oct 2, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Oct 1, 2026